Certain A Shares of Weihai Baihe Biology Technological Co., Ltd. are subject to a Lock-Up Agreement Ending on 26-JAN-2023.
January 25, 2023
Share
Certain A Shares of Weihai Baihe Biology Technological Co., Ltd. are subject to a Lock-Up Agreement Ending on 26-JAN-2023. These A Shares will be under lockup for 373 days starting from 18-JAN-2022 to 26-JAN-2023.
Details:
The controlling shareholder and actual controller Liu Xinli and the companyâs supervisor Liu Zhaomin, have committed not to transfers nor entrustment of shares to any third party nor repurchase by the Company within 36 months since the date of listing of the present shares. If, within 6 months after the issuer's listing, the closing price of the shares is lower than issuance price for 20 consecutive trading days or if trading price is lower than issuance price after 6 month from listing, lock-up period will be automatically extended for another 6 months. If there is any case of dividends, bonus shares, capitalization of capital reserve and other similar cases, issue price will be adjusted according to ex-dividend and ex-interests. After the expiry of the lock-up period (including the extended lock-up period), during the time serves as the company director, supervisor and senior manager, the party promise that yearly transfer of shares made by him/her will not exceed 25% of the holding.
The shareholder Liu Xinqiang has committed not to transfers nor entrustment of shares to any third party nor repurchase by the Company within 36 months since the date of listing of the present shares.
Wang Wentong, Liu Luzeng, Ge Yongle, Wang Lina, Liu Xudong, Sun Tongbo, Yao Jianwei and Liu Haitao have committed not to transfers nor entrustment of shares to any third party nor repurchase by the Company within 12 months since the date of listing of the present shares. If, within 6 months after the issuer's listing, the closing price of the shares is lower than issuance price for 20 consecutive trading days or if trading price is lower than issuance price after 6 month from listing, lock-up period will be automatically extended for another 6 months. If there is any case of dividends, bonus shares, capitalization of capital reserve and other similar cases, issue price will be adjusted according to ex-dividend and ex-interests. After the expiry of the lock-up period (including the extended lock-up period), during the time serves as the company director, supervisor and senior manager, the party promise that yearly transfer of shares made by him/her will not exceed 25% of the holding.
The shareholder GF Xinde Investment Management Co., Ltd., Yantai Chunhua Investment Co., Ltd., Rongcheng Yongli Investment Management Co., Ltd., Shanghai Weimo Investment Partnership (Limited Partnership), Liu Xinzhi and other 31 investor have committed not to transfers nor entrustment of shares to any third party nor repurchase by the Company within 12 months since the date of listing of the present shares.
Weihai Baihe Biology Technological Co Ltd is a China-based company specializing in the research, development, production and sales of nutritional and health food. The Company has formed various dosage forms such as soft capsules, hard capsules, tablets, powders, oral liquids, drops, bottled drinks and bagged drinks. The Company has independent brands such as Baihekang, Fuzi, Hongyangshen and Zulixing, which are aimed at different types of consumer groups such as families, infants, high-end people, middle-aged and elderly people. The Company's products are exported to the United States, Britain, Canada and other countries and regions.